Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Health and Healthcare

Merck : MRK

All Merck Articles

1088 Articles

Chris Lange | Oct 6, 2018 at 7:55 AM EDT

Major Biopharma Catalysts to Watch For in October

Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates…

Lee Jackson | Oct 2, 2018 at 8:45 AM EDT

Analyst Has 5 Stocks to Buy Now With Big Q4 Upside Potential

These five well-known stocks may be laggards but they look like they have solid upside potential, and all can help…

Chris Lange | Sep 29, 2018 at 8:15 AM EDT

Major Biopharma Catalysts on October’s FDA Calendar

Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | Sep 15, 2018 at 8:45 AM EDT

Nike Sprints to First Place as Dow’s Top-Performing Stock

Nike's risky new ad campaign featuring NFL player Colin Kaepernick has paid off in higher sales and increased attention from…

Paul Ausick | Sep 13, 2018 at 4:01 PM EDT

Apple, IBM Lift the Dow Thursday

Apple, IBM, Merck, and Travelers buoyed the Dow index on Thursday.

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Sep 8, 2018 at 8:35 AM EDT

Apple Rolls on as Dow’s Top-Performing Stock

Apple held on to its position as the best performing Dow stock for the year to date last week. Next…

Paul Ausick | Sep 6, 2018 at 4:01 PM EDT

Boeing, Visa Prop Up the Dow Thursday

Boeing, Visa, Merck, and Verizon posted large enough gains to keep the Dow in the green Thursday.

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Paul Ausick | Aug 25, 2018 at 8:40 AM EDT

Nike Back on Top as Dow’s Best-Performing Stock

Nike stock added more than 3% to its share price last week, leading the company to wrestle away from Apple…

Jon C. Ogg | Aug 23, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Paul Ausick | Aug 20, 2018 at 4:01 PM EDT

Nike, Johnson & Johnson Lift the Dow Monday

Nike, Johnson & Johnson, Merck, and Home Depot were Monday's leading gainers.

Paul Ausick | Aug 18, 2018 at 8:50 AM EDT

Apple Returns to Perch as Dow Top-Performing Stock

After an absence of more than a year, Apple is once more the top-performing Dow stock for the year to…

1 … 20 21 22 23 24 … 73

Merck : MRK

All Merck Articles

Major Biopharma Catalysts to Watch For in October

Analyst Has 5 Stocks to Buy Now With Big Q4 Upside Potential

Major Biopharma Catalysts on October’s FDA Calendar

Short Sellers Grow More Selective on Major Pharma Stocks

Nike Sprints to First Place as Dow’s Top-Performing Stock

Apple, IBM Lift the Dow Thursday

Short Sellers Back Off Major Pharma Stocks

Apple Rolls on as Dow’s Top-Performing Stock

Boeing, Visa Prop Up the Dow Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Nike Back on Top as Dow’s Best-Performing Stock

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Nike, Johnson & Johnson Lift the Dow Monday

Apple Returns to Perch as Dow Top-Performing Stock

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Citi Wealth CIO Warns “Infinite AI Agents” Will Accelerate Cybersecurity’s Share of Enterprise Spending

VEA Is Crushing SPY This Year, but the Decade-Long Scorecard Tells a Different Story

Tesla Is $370: Should You Buy?

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

Nebius Explodes 16% Higher on NVIDIA Stake Stunner; CoreWeave Surges 8%, Oracle Adds 5% as AI Cloud Plays Pay Off

Citi Wealth CIO Warns “Infinite AI Agents” Will Accelerate Cybersecurity’s Share of Enterprise Spending

Merck : MRK

All Merck Articles

Major Biopharma Catalysts to Watch For in October

Analyst Has 5 Stocks to Buy Now With Big Q4 Upside Potential

Major Biopharma Catalysts on October’s FDA Calendar

Short Sellers Grow More Selective on Major Pharma Stocks

Nike Sprints to First Place as Dow’s Top-Performing Stock

Apple, IBM Lift the Dow Thursday

Short Sellers Back Off Major Pharma Stocks

Apple Rolls on as Dow’s Top-Performing Stock

Boeing, Visa Prop Up the Dow Thursday

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Nike Back on Top as Dow’s Best-Performing Stock

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Nike, Johnson & Johnson Lift the Dow Monday

Apple Returns to Perch as Dow Top-Performing Stock

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Citi Wealth CIO Warns “Infinite AI Agents” Will Accelerate Cybersecurity’s Share of Enterprise Spending

VEA Is Crushing SPY This Year, but the Decade-Long Scorecard Tells a Different Story

Tesla Is $370: Should You Buy?

Featured Reads

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.